Moreover, it was demonstrated that the HCV infected patients present the translocation involving the oncogene bcl–2 within their peripheral B–lymphocytes, representing a high risk of developing a non–Hodgkin lymphoma. The gene discussed is BCL2; the disease is Hodgkins lymphoma.